Effect of omega-3 supplementation and aerobic training on cardiac risk factors

The effect of 8 weeks aerobic exercise and omega-3 supplementation on cardiac risk factors in elderly men

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201207108559N3

Enrollment

Registered

2013-02-12

Start date

2011-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Cardiovascular risk factors. Condition 2: Lipid profile. - Other abnormal findings of blood chemistry

Interventions

Intervention 1: First group (exercise + Fatty acid supplement): omega-3 supplements 2000 mg daily for 8 weeks containing 2 capsules of 360 mg(EPA) and 240 mg (DHA) plus 8-weeks aerobic exercise traini

Placebo

First group (exercise + Fatty acid supplement): omega-3 supplements 2000 mg daily for 8 weeks containing 2 capsules of 360 mg(EPA) and 240 mg (DHA) plus 8-weeks aerobic exercise training program consi

Second group (no exercise + Fatty acid supplement): omega-3 supplements 2000 mg daily for 8 weeks containing 2 capsules of 360 mg(EPA) and 240 mg (DHA) and no exercise

Third group (no exercise + placebo supplement): placebo capsules identical to fatty acid supplement capsules and no exercise

Fourth group (exercise + placebo supplement): 8-weeks aerobic exercise training program consisted of three sessions per week, for a period of 30 to 45 minutes maximum heart rate and a set intensity (5

Eligibility

Sex/Gender

Male

Age

54 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Male, Elderly, Non-Athletic, Healthy Men, Pre-test tests Exclusion criteria: In the absence of continuous testing, Lack of omega-3 supplements in the training, Do not post- test tests, Men less than 50 years

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
TG. Timepoint: Before the intervention, two months after the intervention. Method of measurement: Lab methods.	—

Secondary

Measure	Time frame
TC. Timepoint: Before the intervention, two months after the intervention. Method of measurement: Lab methods.;LDL-C. Timepoint: Before the intervention, two months after the intervention. Method of measurement: Lab methods.;HDL-C. Timepoint: Before the intervention, two months after the intervention. Method of measurement: Lab methods.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactYounes Khademi

Ministry of Education

younes.khademi@yahoo.com+98 73 2646 3125

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026